Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
09/2014
09/11/2014US20140256652 Polypeptides Involved In Immune Response
09/11/2014US20140255497 Organic Compounds
09/10/2014EP2774932A1 Novel compound contained in manuka honey and use of same
09/10/2014EP2774919A1 Novel sulfonamide TRPA1 receptor antagonists
09/10/2014EP2774914A1 N-benzylaniline derivative and uses thereof
09/10/2014EP2774912A1 Cationic lipid
09/10/2014EP2774617A1 Medical composition containing stauntonia hexaphylla extract
09/10/2014EP2773645A1 Imidazopyridazine compounds
09/10/2014EP2773378A1 Prodrugs of non- steroid anti - inflammatory agents (nsaids)
09/10/2014EP2773376A1 Polyethylene glycol based prodrug of adrenomedullin and use thereof
09/10/2014EP2773325A1 Liposomal corticosteroids for treatment of inflammatory disorders in humans
09/09/2014US8828973 Compounds as receptor modulators with therapeutic utility
09/09/2014US8828969 Pharmaceutical composition for relieving pain
09/09/2014US8828959 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells
09/09/2014US8828947 Polypeptide formulation
09/09/2014US8828669 Methods of screening for a compound that inhibits the interaction between BAFF and BCMA
09/09/2014US8828359 Particulate materials
09/09/2014CA2774040C 2, 3-dihydro-1h-inden-2-yl urea derivatives and medical uses thereof
09/09/2014CA2666582C Acetaminophen / ibuprofen combinations
09/09/2014CA2655750C 2-arylindole derivatives as mpges-1 inhibitors
09/09/2014CA2473733C Cytokine receptor zcytor17 multimers
09/04/2014WO2014134391A1 Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors
09/04/2014WO2014134388A1 Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors
09/04/2014WO2014134313A1 Intermediates for use in the preparation of indazole derivatives and processes for the preparation thereof
09/04/2014WO2014134127A1 Cannabinergic nitrate esters and related analogs
09/04/2014US20140249185 Therapeutic Agents Useful for Treating Pain
09/04/2014US20140249092 Cyclosporin analog formulations
09/04/2014US20140248661 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use
09/03/2014EP2772498A1 Polypeptides inhibiting neovascularization and uses thereof
09/03/2014EP2772486A1 Kinase inhibitor and method for treatment of related diseases
09/03/2014EP2771335A2 (4-phenylimidazol-2-yl) ethylamine derivatives useful as sodium channel modulators
09/03/2014EP2771334A1 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies
09/03/2014EP2771329A1 Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
09/03/2014EP2771322A2 Novel trpv3 modulators
09/03/2014EP2771321A1 Hydroxamate derivatives for hdac inhibitor, and the pharmaceutical composition comprising thereof
09/03/2014EP2771320A1 Cyclohexylamines
09/03/2014EP2771069A2 Inhibiting g protein coupled receptor 6 kinase polypeptides
09/03/2014EP2770984A1 Device and method for sustained release of therapeutic agent
09/02/2014US8824784 System for image analysis in a network that is structured with multiple layers and differentially weighted neurons
09/02/2014US8822685 2,4-pyrimidinediamine compounds and their uses
09/02/2014US8822637 Somatostatin analogues
09/02/2014US8822481 Salts of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
09/02/2014US8822474 6,7-dihydrothieno[3,2-d]pyrimidine for the treatment of inflammatory diseases
09/02/2014US8822435 Bisphosphonate compounds
09/02/2014US8822169 HMG1 antibody for treating inflammatory conditions
09/02/2014US8821851 Inflammation-inhibitory serum factors and uses thereof
09/02/2014CA2651128C Benzimidazole modulators of vr1
08/2014
08/28/2014WO2014130947A1 Pyrazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
08/28/2014WO2014130638A1 Combinations of indigo naturalis and berberine and uses thereof
08/28/2014WO2014130068A1 Methods for increasing oral ostenogenesis using lipoxin a4 (lxa4) and its analogs
08/28/2014WO2014129969A1 Therapeutic agents
08/28/2014WO2014128655A1 Substituted imidazo[4,5-c]quinoline derivatives as bromodomain inhibitors
08/28/2014WO2014128486A1 Pyrimidine compounds useful in the treatment of diseases mediated by ikke and/or tbk1 mechanisms
08/28/2014WO2014128240A1 Inhibitors of na(v) 1.9 channel activity and uses thereof for treating pain
08/28/2014WO2014128093A1 Substituted-imidazo[1,2-b]pyridazines as mknk1 inhibitors
08/28/2014WO2014081343A3 Pharmaceutical composition containing nalbuphine hydrochloride, use thereof to treat moderate to severe pain and method for producing said pharmaceutical composition
08/28/2014US20140243413 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
08/28/2014US20140242086 Polynucleotides encoding signal peptide-containing molecules
08/27/2014EP2769993A1 Antibodies against human NKG2D and uses thereof
08/27/2014EP2769724A1 Inhibitors of Na(v) 1.9 channel activity and uses thereof for treating pain
08/27/2014EP2769718A1 Medicinal composition
08/27/2014EP2769715A2 Methods for treating autoimmune disorders, and reagents related thereto
08/27/2014EP2769713A1 Solid oral composition comprising a S1P receptor agonist and a sugar alcohol
08/27/2014EP2768859A1 Antagonists of il17c for the treatment of inflammatory disorders
08/27/2014EP2768813A1 Quinazoline derivatives as pi3k modulators
08/27/2014EP2768810A1 Compounds that modulate intracellular calcium
08/27/2014EP2768478A1 Paste comprising non-steroidal anti-inflammatory
08/26/2014US8815821 Double-stranded oligonucleotides
08/26/2014US8815795 Methods for preventing or treating eye diseases using adiponectin
08/26/2014US8815300 Composition and methods for relief of neuropathological pain
08/26/2014US8815292 Compositions and methods for treating insulin resistance and diabetes mellitus
08/26/2014US8815268 Oat extracts: refining, compositions and methods of use
08/26/2014CA2476755C Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
08/21/2014WO2014126972A1 Substituted bisphenyl butanoic acid derivatives as nep inhibitors with improved in vivo efficacy
08/21/2014WO2014126486A1 Pharmacological indications and uses of preparations from dioscorea hispida
08/21/2014WO2014125444A1 Heterocyclic amides as kinase inhibitors
08/21/2014WO2014125413A1 Ip receptor agonist heterocyclic compounds
08/21/2014WO2014124560A1 Mglur regulators
08/21/2014WO2014096388A3 Novel benzimidazole derivatives as kinase inhibitors
08/21/2014WO2014091298A3 Nitrogen containing morphinan derivatives and the use thereof
08/21/2014US20140235832 Rank ligand polypeptides
08/21/2014US20140235721 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
08/21/2014US20140234902 Methods for producing modified glycoproteins
08/21/2014US20140234225 Method of treatment using nanoparticulate compositions having lysozyme as a surface stabilizer
08/20/2014EP2767537A1 Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)
08/20/2014EP2767273A1 Death-associated protein kinases, inhibitors and activators thereof for use in pharmaceutical compositions and in predictive medicine
08/20/2014EP2766368A1 5,7-substituted-imidazo[1,2-c]pyrimidines
08/20/2014EP2766344A1 Ep1 receptor ligands
08/20/2014EP2766032A1 Topical formulations of chemerin c15 peptides for the treatment of dermatological conditions
08/20/2014EP2766019A1 Anti-inflammatory compounds
08/19/2014US8809530 Compositions of protein receptor tyrosine kinase inhibitors
08/19/2014US8809327 Sulfonamides as TRPM8 modulators
08/19/2014US8809323 Therapeutic applications of pro-apoptotic benzodiazepines
08/19/2014US8809281 Small peptides and methods for blocking IGE mediated activation of an immune cell
08/19/2014US8808742 Compositions and methods for preparing and using same
08/19/2014CA2709865C Method for improved breast milk feeding to reduce the risk of allergy
08/19/2014CA2602545C Phenyl-n-acyl derivatives of amines and amino acids, a process for the preparation thereof, a pharmaceutical composition and the use thereof
08/19/2014CA2562473C Preventive and/or therapeutic agent for inflammatory bowel diseases
08/19/2014CA2482718C Derivatives of the il-2 receptor gamma chain, their production and use
08/19/2014CA2475338C Treatment of ophthalmic disorders using urea and urea derivatives
1 ... 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 ... 1272